ACM Central Laboratory Expands its Business Development Team
ACM Central Laboratory, a central lab specializing in safety and specialty testing for clinical trials, announced expansion of its business development team by more than 100%.
Rochester, New York -- April 4, 2005 -- ACM Central Laboratory, a central lab specializing in safety and specialty testing for clinical trials, announced expansion of its business development team by more than 100%. Overwhelming demand for ACM Central Laboratory Services by new and existing customers has led to this growth.
ACM Central Laboratory Services has added U.S. business development directors in the Northeast, Southeast and on the West Coast. Tim Robey, Scott Keddy, Tab Moore and James Naumann join ACM's team of talented professionals. Highly experienced, these directors bring extensive knowledge of the clinical development industry. Their experience includes operational, clinical and business development responsibilities within contract research organizations (CRO), central labs, and pharmaceutical and biotech companies. In addition to sales in their respective regions, the directors will be responsible for ongoing client communication and ensuring customer satisfaction.
Realtime Electronic Data Capture at Investigator Sites: Laboratory Data and Beyond
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
